Get our introductory offer at only
*$0.99/month for first 3 months
$29.90/month for the next 9 months
VALEANT Pharmaceuticals International Inc, the embattled Canadian drugmaker, has agreed to sell about US$2.1 billion in assets to get cash to streamline its businesses and begin easing its debt burden.
L'Oreal SA will pay Valeant US$1.3 billion for three skincare brands, the